Report Detail
Global Poliovirus Vaccine Market Insights and Forecast to 2026
- RnM4139606 |
- 17 August, 2020 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Poliovirus Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Poliovirus Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Poliovirus Vaccine market is segmented into
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Segment by Application, the Poliovirus Vaccine market is segmented into
Public
Private
Regional and Country-level Analysis
The Poliovirus Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Poliovirus Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Poliovirus Vaccine Market Share Analysis
Poliovirus Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Poliovirus Vaccine business, the date to enter into the Poliovirus Vaccine market, Poliovirus Vaccine product introduction, recent developments, etc.
The major vendors covered:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
1 Study Coverage
- 1.1 Poliovirus Vaccine Product Introduction
- 1.2 Market Segments
- 1.3 Key Poliovirus Vaccine Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Poliovirus Vaccine Market Size Growth Rate by Type
- 1.4.2 Inactivated Polio Vaccine (IPV)
- 1.4.3 Oral Polio Vaccine (OPV)
- 1.5 Market by Application
- 1.5.1 Global Poliovirus Vaccine Market Size Growth Rate by Application
- 1.5.2 Public
- 1.5.3 Private
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Poliovirus Vaccine Market Size, Estimates and Forecasts
- 2.1.1 Global Poliovirus Vaccine Revenue 2015-2026
- 2.1.2 Global Poliovirus Vaccine Sales 2015-2026
- 2.2 Global Poliovirus Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Poliovirus Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Poliovirus Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Poliovirus Vaccine Competitor Landscape by Players
- 3.1 Poliovirus Vaccine Sales by Manufacturers
- 3.1.1 Poliovirus Vaccine Sales by Manufacturers (2015-2020)
- 3.1.2 Poliovirus Vaccine Sales Market Share by Manufacturers (2015-2020)
- 3.2 Poliovirus Vaccine Revenue by Manufacturers
- 3.2.1 Poliovirus Vaccine Revenue by Manufacturers (2015-2020)
- 3.2.2 Poliovirus Vaccine Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Poliovirus Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Poliovirus Vaccine Revenue in 2019
- 3.2.5 Global Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Poliovirus Vaccine Price by Manufacturers
- 3.4 Poliovirus Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Poliovirus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Poliovirus Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Poliovirus Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Poliovirus Vaccine Market Size by Type (2015-2020)
- 4.1.1 Global Poliovirus Vaccine Sales by Type (2015-2020)
- 4.1.2 Global Poliovirus Vaccine Revenue by Type (2015-2020)
- 4.1.3 Poliovirus Vaccine Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Poliovirus Vaccine Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Poliovirus Vaccine Sales Forecast by Type (2021-2026)
- 4.2.2 Global Poliovirus Vaccine Revenue Forecast by Type (2021-2026)
- 4.2.3 Poliovirus Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Poliovirus Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Poliovirus Vaccine Market Size by Application (2015-2020)
- 5.1.1 Global Poliovirus Vaccine Sales by Application (2015-2020)
- 5.1.2 Global Poliovirus Vaccine Revenue by Application (2015-2020)
- 5.1.3 Poliovirus Vaccine Price by Application (2015-2020)
- 5.2 Poliovirus Vaccine Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Poliovirus Vaccine Sales Forecast by Application (2021-2026)
- 5.2.2 Global Poliovirus Vaccine Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Poliovirus Vaccine Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Poliovirus Vaccine by Country
- 6.1.1 North America Poliovirus Vaccine Sales by Country
- 6.1.2 North America Poliovirus Vaccine Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Poliovirus Vaccine Market Facts & Figures by Type
- 6.3 North America Poliovirus Vaccine Market Facts & Figures by Application
7 Europe
- 7.1 Europe Poliovirus Vaccine by Country
- 7.1.1 Europe Poliovirus Vaccine Sales by Country
- 7.1.2 Europe Poliovirus Vaccine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Poliovirus Vaccine Market Facts & Figures by Type
- 7.3 Europe Poliovirus Vaccine Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Poliovirus Vaccine by Region
- 8.1.1 Asia Pacific Poliovirus Vaccine Sales by Region
- 8.1.2 Asia Pacific Poliovirus Vaccine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Poliovirus Vaccine Market Facts & Figures by Type
- 8.3 Asia Pacific Poliovirus Vaccine Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Poliovirus Vaccine by Country
- 9.1.1 Latin America Poliovirus Vaccine Sales by Country
- 9.1.2 Latin America Poliovirus Vaccine Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Poliovirus Vaccine Market Facts & Figures by Type
- 9.3 Central & South America Poliovirus Vaccine Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Poliovirus Vaccine by Country
- 10.1.1 Middle East and Africa Poliovirus Vaccine Sales by Country
- 10.1.2 Middle East and Africa Poliovirus Vaccine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Poliovirus Vaccine Market Facts & Figures by Type
- 10.3 Middle East and Africa Poliovirus Vaccine Market Facts & Figures by Application
11 Company Profiles
- 11.1 Sanofi
- 11.1.1 Sanofi Corporation Information
- 11.1.2 Sanofi Description and Business Overview
- 11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Sanofi Poliovirus Vaccine Products Offered
- 11.1.5 Sanofi Related Developments
- 11.2 GSK
- 11.2.1 GSK Corporation Information
- 11.2.2 GSK Description and Business Overview
- 11.2.3 GSK Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 GSK Poliovirus Vaccine Products Offered
- 11.2.5 GSK Related Developments
- 11.3 Bibcol
- 11.3.1 Bibcol Corporation Information
- 11.3.2 Bibcol Description and Business Overview
- 11.3.3 Bibcol Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Bibcol Poliovirus Vaccine Products Offered
- 11.3.5 Bibcol Related Developments
- 11.4 Serum Institute
- 11.4.1 Serum Institute Corporation Information
- 11.4.2 Serum Institute Description and Business Overview
- 11.4.3 Serum Institute Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Serum Institute Poliovirus Vaccine Products Offered
- 11.4.5 Serum Institute Related Developments
- 11.5 Tiantan Biological
- 11.5.1 Tiantan Biological Corporation Information
- 11.5.2 Tiantan Biological Description and Business Overview
- 11.5.3 Tiantan Biological Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Tiantan Biological Poliovirus Vaccine Products Offered
- 11.5.5 Tiantan Biological Related Developments
- 11.6 IMBCA
- 11.6.1 IMBCA Corporation Information
- 11.6.2 IMBCA Description and Business Overview
- 11.6.3 IMBCA Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 IMBCA Poliovirus Vaccine Products Offered
- 11.6.5 IMBCA Related Developments
- 11.7 Panacea Biotec Ltd
- 11.7.1 Panacea Biotec Ltd Corporation Information
- 11.7.2 Panacea Biotec Ltd Description and Business Overview
- 11.7.3 Panacea Biotec Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Panacea Biotec Ltd Poliovirus Vaccine Products Offered
- 11.7.5 Panacea Biotec Ltd Related Developments
- 11.8 Bio-Med
- 11.8.1 Bio-Med Corporation Information
- 11.8.2 Bio-Med Description and Business Overview
- 11.8.3 Bio-Med Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Bio-Med Poliovirus Vaccine Products Offered
- 11.8.5 Bio-Med Related Developments
- 11.9 Halfkin Bio-Pharmaceuticals
- 11.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
- 11.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
- 11.9.3 Halfkin Bio-Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Products Offered
- 11.9.5 Halfkin Bio-Pharmaceuticals Related Developments
- 11.1 Sanofi
- 11.1.1 Sanofi Corporation Information
- 11.1.2 Sanofi Description and Business Overview
- 11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Sanofi Poliovirus Vaccine Products Offered
- 11.1.5 Sanofi Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Poliovirus Vaccine Market Estimates and Projections by Region
- 12.1.1 Global Poliovirus Vaccine Sales Forecast by Regions 2021-2026
- 12.1.2 Global Poliovirus Vaccine Revenue Forecast by Regions 2021-2026
- 12.2 North America Poliovirus Vaccine Market Size Forecast (2021-2026)
- 12.2.1 North America: Poliovirus Vaccine Sales Forecast (2021-2026)
- 12.2.2 North America: Poliovirus Vaccine Revenue Forecast (2021-2026)
- 12.2.3 North America: Poliovirus Vaccine Market Size Forecast by Country (2021-2026)
- 12.3 Europe Poliovirus Vaccine Market Size Forecast (2021-2026)
- 12.3.1 Europe: Poliovirus Vaccine Sales Forecast (2021-2026)
- 12.3.2 Europe: Poliovirus Vaccine Revenue Forecast (2021-2026)
- 12.3.3 Europe: Poliovirus Vaccine Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Poliovirus Vaccine Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Poliovirus Vaccine Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Poliovirus Vaccine Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Poliovirus Vaccine Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Poliovirus Vaccine Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Poliovirus Vaccine Sales Forecast (2021-2026)
- 12.5.2 Latin America: Poliovirus Vaccine Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Poliovirus Vaccine Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Poliovirus Vaccine Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Poliovirus Vaccine Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Poliovirus Vaccine Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Poliovirus Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Poliovirus Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Poliovirus Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Poliovirus Vaccine. Industry analysis & Market Report on Poliovirus Vaccine is a syndicated market report, published as Global Poliovirus Vaccine Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Poliovirus Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
